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Synopsis: 
 
Our results demonstrate that transport of herpes simplex virus-1 glycoproteins to the plasma membrane prior to endocytosis 
is the major route by which these envelope proteins are localized to cytoplasmic virus assembly compartments. We show 
that this process requires dynamin and that internalization of glycoprotein complexes can employ clathrin-dependent and/or 
independent pathways. 
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Abstract 
Herpes simplex virus-1 (HSV-1) is a large enveloped 
DNA virus that belongs to the family of Herpesviridae. It 
has been recently shown that the cytoplasmic 
membranes that wrap the newly assembled capsids are 
endocytic compartments derived from the plasma 
membrane. Here we show that dynamin-dependent 
endocytosis plays a major role in this process. 
Dominant-negative dynamin and clathrin adaptor AP180 
significantly decrease virus production. Moreover 
inhibitors targeting dynamin and clathrin lead to a 
decreased transport of glycoproteins to cytoplasmic 
capsids confirming that glycoproteins are delivered to 
assembly sites via endocytosis. We also show that 
certain combinations of glycoproteins colocalize with 
each other and with the components of clathrin-
dependent and clathrin-independent endocytosis 
pathways. Importantly, we demonstrate that the uptake 
of neutralizing antibodies that bind to glycoproteins when 
they become exposed on the cell surface during virus 
particle assembly leads to the production of non-
infectious HSV-1. Our results demonstrate that transport 
of viral glycoproteins to the plasma membrane prior to 
endocytosis is the major route by which these proteins 
are localized to the cytoplasmic virus assembly 
compartments. This highlights the importance of 
endocytosis as a major protein-sorting event during 
HSV-1 envelopment.  
 
 
Introduction 
 
Herpes simplex virus-1 (HSV-1) is a common human 
pathogen responsible for cold sores. In rare cases it also 
leads to herpes keratitis and herpes simplex 
encephalitis, which can progress to blindness and death, 
respectively [1,2]. Primary HSV-1 infection usually 
occurs early in life and results in a latent but lifelong 
infection with a seroprevalence of 50 to 80% among 
adults in Western countries [3]. HSV-1 and 2 can also 
cause serious disease in transplant recipients that in 
many cases is prevented by oral acyclovir prophylaxis 
[3].  
 
HSV-1 belongs to the Herpesviridae family of large, 
enveloped DNA viruses. HSV-1 establishes latency in 
sensory neurons but during primary infection and 
reactivation it lytically replicates in epithelial cells. The 
entry of HSV-1 into permissive cells is dependent on 
viral glycoproteins and host cell factors. The virus can 
penetrate a cell via direct fusion at the plasma 
membrane (PM) or with an endosomal membrane 
following endocytosis of the virion. The route of entry is 
dependent on cell type as well as other conditions that 
are not completely understood (reviewed in [4,5]). After 
membrane fusion, capsids are transported on 
microtubules to the nucleus and the tegument protein 
pUL36 has been shown to be crucial for this process [6]. 
Viral DNA enters the nucleus through the nuclear pore 
and viral gene expression is initiated, with the nucleus 
being the site of viral genome replication and assembly 
of new capsids. Newly synthesized DNA-containing 
capsids (nucleocapsids) are then transported to the 
cytoplasm in a process called primary envelopment/de-
envelopment, where nucleocapsids bud at the inner 
nuclear membrane to form an enveloped particle in the 
perinuclear space, which then fuses with the outer 
nuclear membrane [7,8]. Finally, assembly of infectious 
virions occurs in the cytoplasm, where the nucleocapsids 
acquire the full complement of tegument proteins and 
the viral glycoprotein-containing lipid envelope through a 
process of budding/wrapping at intracellular membranes 
to form an enveloped virus contained within the lumen of 
a large vesicle/vacuole. Fully assembled particles are 
secreted out from cells via an exocytic process.  
 
The origin of membrane material for the secondary 
envelopment of HSV-1 remains a matter of debate. The 
presence of viral glycoproteins at the PM has been 
observed in many studies but there is a limited 
understanding of the possible functions of HSV-1 
glycoproteins at the cell surface during normal viral life-
cycle. Some glycoprotein-specific functions have been 
suggested previously for glycoprotein M (gM) which re-
localizes both viral and cellular proteins from the PM to 
intracellular compartments and can antagonize the anti-
viral function of tetherin [9–11]. Similarly, the gK/pUL20 
complex has also been shown to re-localize other viral 
glycoproteins to intracellular compartments [12]. Another 
glycoprotein complex – gE/gI functions as an Fc receptor 
and binds Fc fragments of antibodies thus decreasing 
humoral response to infection [13,14]. Furthermore, 
HSV-1 glycoproteins have recently been demonstrated 
to follow Rab6-dependent post-Golgi trafficking to the 
PM. This step was shown to be crucial for the virus 
production [15] suggesting that transport of glycoproteins 
to the PM is necessary for the virus assembly process. 
Previous reports suggested that wrapping membranes 
might originate from multivesicular bodies (MVB) [16] 
or/and from the trans-Golgi Network (TGN) [17–19], 
however a recent study demonstrated that endocytic 
tubules are a major source of membrane for secondary 
envelopment [20]. The authors of the latter study used 
horseradish peroxidase (HRP) as a fluid-phase marker 
for endocytosis and showed that HRP positive tubules 
wrapped capsids after 10-30 min incubation. 
Furthermore, this process was shown to be Rab5 and 
Rab11 dependent [20]. Overall, these data suggest that 
HSV-1 glycoproteins are first trafficked to the PM and 
then travel to virus assembly sites by endocytosis. 
 
Here, we investigate the mechanism of HSV-1 
glycoprotein endocytosis during the viral assembly 
process using functional assays. In particular, we 
investigated the role of dynamin, a member of the 
GTPase family, which is involved in the scission of 
endocytic vesicles from the PM. By employing dominant-
negative proteins and inhibitors we now show that 
dynamin function is important for both glycoprotein 
internalization and production of infectious viral particles. 
The same methodology to target clathrin assembly 
resulted in similar but less pronounced effects on 
glycoprotein endocytosis and production of infectious 
particles, suggesting that although clathrin-dependent 
endocytosis is involved, clathrin-independent routes also 
contribute. This is further supported by evidence we 
obtained from optical super-resolution microscopy, which 
shows that glycoproteins colocalize with both clathrin-
dependent endocytosis marker (AP2) and the clathrin-
independent caveolae marker (Cav-1), suggesting that 
both pathways may be important for HSV-1 assembly. 
Furthermore we show that antibodies targeting HSV-1 
glycoproteins added to cells during the time-frame of 
Page 2 of 25Traffic
For Peer Review
 
virus assembly are incorporated into virions and potently 
neutralize infectivity of newly produced viral particles. 
Our study clearly demonstrates an important 
requirement for endocytosis to deliver viral envelope 
proteins to assembling HSV-1 particles. 
 
 
Results 
 
Neutralizing antibodies delivered to assembly sites 
with endocytosed gD and gH/gL are incorporated 
into secreted particles. Results obtained by 
Hollinshead et al. [20] suggest that glycoproteins travel 
to assembly sites via the PM. We first decided to confirm 
this hypothesis through the use of neutralizing 
antibodies. We predicted that glycoprotein-specific 
antibodies added to the extracellular media during the 
HSV-1 assembly process should be incorporated into 
virions. In this process, antibodies would bind to their 
corresponding glycoproteins that have been exposed on 
the cell surface, and the conjugated complex would then 
traffic to the intracellular assembly compartments. To 
verify this hypothesis we used neutralizing antibodies 
against gD (LP2) and gH/gL (LP11). Non-neutralizing 
antibodies (AP7 for gD and BBH-1 for gH) and an 
antibody specific to the tegument protein VP16 (LP1) 
were used as negative controls. We added 5 g.ml-1 of 
purified antibodies to HaCaT cells 1 h post infection and 
harvested cell-associated viruses after 16 h incubation. 
In order to specifically quantify intracellular infectivity 
cells were harvested using trypsinization to remove or 
destroy all extracellular infectivity. Trypsin treatment 
removed on average 65-85 % of cell-associated 
infectivity in these experiments. As shown in Figure 1A 
both neutralizing antibodies (LP2 and LP11) significantly 
decreased intracellular virus infectivity (down to ~20 and 
40 % of the control, respectively) whereas no such effect 
was observed for control antibodies (LP1, AP7 and BBH-
1). Experiments were also performed in COS7 cells and 
similar results were observed (Figure S1). Given the 
extended period of exposure of infected cells to 
antibodies in these experiments (16 h), we investigated 
the localization of internalized antibodies by 
immunofluorescence microscopy. Antibody signal was 
detected in numerous puncta throughout the cytoplasm 
but demonstrated no colocalization with the Golgi, 
suggesting internalized HSV-1 gD or gH/gL remain in the 
endocytic pathway and do not traffic to the Golgi 
complex to any detectable levels after internalization 
from the plasma membrane (Figure S1). Furthermore, 
we also examined the level of intracellular infectivity 
when neutralizing antibodies to gD (LP2) were added to 
cells only for the last 30-60 min of infection, and under 
these conditions intracellular virus infectivity was 
reduced to 38-46 % of the control. These data suggest 
the neutralization of intracellular virus in these 
experiments is not simply due to non-specific saturation 
of the cellular secretory and endocytic pathways with 
antibodies.  
To confirm that these results were due to neutralization 
of infectivity rather than any indirect effect on virus 
assembly or release, we collected supernatants from 
infected HaCaT cells and pelleted viruses for analysis by 
western blot. Figure 1B shows that particles were 
released from cells at a similar level regardless of the 
presence of antibodies and therefore the observed 
reduction in infectivity is unlikely to be caused by defects 
in virion assembly. In fact a slight increase in particle 
release was observed where anti-gD antibodies were 
used. This could explain the significant increase in 
infectivity observed with the non-neutralizing AP7 
antibody. Currently, we are not able to explain this 
phenomenon, although it is conceivable that IgG-
mediated cross-linking of gD molecules could enhance 
the stability of tegument interactions with the cytoplasmic 
domain of gD, thereby increasing the efficiency of 
assembly. 
IgG heavy chains were detected in western blot analysis 
of cell lysate and/or secreted virus samples for all 
glycoprotein-specific antibodies (LP2, AP7, LP11 and 
BBH-1) that were added to the media of infected cells 
(Figure 1A and B) confirming that they are internalized 
into cells and remain attached to secreted viruses. In 
contrast, VP16-specific antibody (LP1) was not present 
in western blot samples, as predicted for an antibody 
that recognizes a virion protein that does not become 
exposed to the extracellular environment. Levels of gD-
specific antibody heavy chain present in cell lysate and 
secreted virus samples analyzed were comparable. 
Interestingly there was a marked difference observed for 
anti-gH antibodies as only faint heavy chain bands were 
detected in cellular lysates but strong bands were 
observed for secreted virion samples. This suggests that 
of the population of gD and gH molecules that become 
exposed on the PM and then internalized, a greater 
proportion of gH is incorporated into virions, perhaps 
suggesting more efficient targeting of internalized gH to 
virus assembly sites.  
Overall, these results confirm that both gD and the 
gH/gL complex traffic to the PM and become internalized 
prior to being targeted to intracellular sites of virus 
envelopment. 
 
Dominant-negative dynamin decreases the 
production of infectious HSV-1. Next we looked into 
th  mechanism of glycoprotein endocytosis. Dynamin 2 
is a protein necessary for pinching off endocytic vesicles 
from the PM [21]. Inhibition of dynamin activity impairs 
both clathrin-dependent and independent pathways [22]. 
To investigate the role of dynamin in HSV-1 assembly, 
we employed dominant-negative dynamin K44A in a 
transfection-based UL36 complementation assay 
described previously [23]. Briefly, this assay is based on 
the ability to complement the replication defect of a HSV-
1 virus lacking the UL36 gene, which is essential for 
virus assembly, by expressing UL36 from a transfected 
plasmid. COS-7 cells were co-transfected with a UL36 
expression plasmid together with a plasmid encoding the 
protein of interest (e.g. dominant-negative dynamin). 
Subsequently, cells were infected with HSV-1UL36; 
productive virus replication of a UL36 deletion virus only 
occurs in UL36 expressing (transfected) cells and thus 
infected but untransfected cells do not influence the 
results. The production of infectious virus progeny was 
determined by plaque assay using a stable UL36 
complementing cell line. We also used a dominant 
negative form of AP180 (AP180-C), which is an adaptor 
necessary for clathrin-dependent endocytosis [24]. We 
have previously shown that endosomal sorting complex 
required for transport (ESCRT) proteins play an 
important role in HSV-1 assembly, therefore dominant 
negative VSP4 (VPS4EQ), which potently blocks 
ESCRT function, was used as a control [25]. As shown 
in Figure 2A expression of dynamin K44A decreased 
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production of infectious virus particles by approximately 
90%. In comparison, expression of dominant negative 
AP180-C reduced infectious virus production by 
approximately 50%. The uptake of transferrin, which is 
clathrin-dependent, into cells expressing AP180-C or 
dynamin K44A transfected cells was strongly inhibited as 
expected, confirming the activity of these dominant 
negative constructs (Figure 2B).  The greater effect of 
dynamin K44A compared to AP180-C on production of 
infectious HSV-1 suggests that clathrin-independent 
pathways may also participate in HSV-1 glycoprotein 
endocytosis. The discrepancy between AP180-C and 
dynamin results could also be explained by the fact that 
dynamin 2 is necessary for trafficking of vesicles from 
the Golgi to the PM [26]. However, immunofluorescence 
experiments clearly show accumulation of gD at the PM 
(Figure 2C) in dynamin K44A transfected cells 
supporting the notion that the effect is primarily due to 
inhibition of clathrin-independent endocytosis and not 
Golgi-to-PM trafficking. Similar results were also 
observed for other HSV-1 envelope proteins gB and gE 
(Figure S2). To verify whether glycoproteins traffic to 
intracellular virus assembly sites via the PM we 
performed antibody-uptake experiments using gD 
specific antibodies in cells infected with HSV-1 
expressing the capsid protein VP26 fused to a 
fluorescent protein mTurquoise (Figure 2C). These 
experiments and all subsequent fluorescence 
microscopy experiments were performed at 8 h post 
infection, a mid point of the HSV-1 replication cycle 
when virions are being assembled. This allows more 
reliable identification of enveloped and non-enveloped 
capsids in the cytoplasm by fluorescence microscopy 
because newly assembling virions are better separated 
and cells are less saturated with viral proteins compared 
to later times of infection. In cells expressing WT 
dynamin, antibodies bound to gD were re-localized into 
capsid-positive puncta whereas in cells expressing 
dynamin K44A very few puncta where gD co-localized 
with capsids were present. In addition, accumulation of 
gD/capsid-positive particles (enveloped virions) near the 
cell periphery was clearly observed in WT dynamin 
expressing cells but not in dynamin K44A expressing 
cells (Figure 2C), suggesting that the inhibition of 
dynamin-dependent endocytosis prevents gD reaching 
virus assembly compartments. Taken together, these 
results suggest that dynamin-dependent endocytosis is 
important for assembly of infectious HSV-1 particles by 
mediating the delivery of glycoproteins such as gD to the 
assembly sites.  
 
Endocytosis inhibitors prevent glycoproteins from 
incorporation into mature virions. Our results from 
dominant-negative dynamin and AP180 experiments 
show decrease in virus titer when endocytosis and 
subsequent trafficking of glycoproteins from the PM to 
assembly sites is impaired. However, as mentioned 
above it is possible that these effects might be partially 
due to reduced glycoprotein trafficking through the 
secretory pathway between the Golgi and the PM due to 
inhibition of dynamin and/or clathrin function at the TGN. 
In order to more directly investigate the role of 
endocytosis, we performed experiments to examine the 
trafficking of HSV glycoproteins in the presence or 
absence of endocytosis inhibitors. To inhibit dynamin 
activity we used Dynole-34-2 (Dynole), which 
allosterically inhibits the GTPase activity of dynamin, and 
the inactive form, Dynole-31-2, as a control (Dynole 
Negative). Inhibition of clathrin assembly was achieved 
using Pitstop 2 and the inactive form, Pitstop 2 Negative, 
as a control. We used antibody-uptake experiments in 
cells infected with HSV-1 for 8 h and incubating cells 
with inhibitors or control compounds for the final 30 
minutes prior to fixation to analyze how these inhibitors 
affect glycoprotein trafficking to assembly sites while 
avoiding non-specific effects that may occur due to 
prolonged endocytosis inhibition. Firstly, we assessed 
the effect of the inhibitors on uptake of transferrin and 
glycoprotein-specific antibodies into HFF-Tert (Figure 3) 
and COS7 cells (Figure S3). Active compounds 
significantly decreased transferrin uptake into both cell 
lines, confirming their activity. In infected cells both 
Dynole and Pitstop 2 changed the localization of HSV-1 
glycoproteins in the cells, and in all cases increased the 
accumulation of antibodies at the PM and decreased the 
amount of intracellular puncta; these puncta are likely to 
be either endosomes or assembled viral particles (Figure 
3B and Figure S3B). 
The uptake experiments also showed that the inhibition 
of glycoprotein endocytosis is less effective with PitStop 
2 (which blocked transferrin uptake at comparable levels 
to Dynole) because greater numbers of intracellular 
puncta were still visible compared to Dynole treatment, 
especially in COS7 cells (Figure 3 and Figure S3). 
These data also support the notion that clathrin-
independent mechanisms contribute to glycoprotein 
internalization.  
To examine glycoprotein endocytosis inhibition in more 
detail we focused on gD trafficking to intracellular 
capsids. For these experiments, we infected HFF-Tert 
cells for 8 h with a doubly fluorescent virus expressing 
VP26-mTurquoise (capsid) and gM-EYFP (envelope) to 
allow simple identification, and discrimination of 
enveloped and non-enveloped capsids in the cytoplasm, 
and treated them with inhibitors for 30 min, with gD 
antibody added to the extracellular media for the final 15 
min. As shown in Figure 4 and Figure S4A, within 15 min 
of antibody uptake, the control cells (Dynole Negative 
and Pitstop 2 negative-treated) accumulated several gD 
positive puncta, many of which were capsid-positive, 
thus likely enveloped particles. These data confirm that 
glycoproteins (gD in this instance) are delivered from the 
PM to cytoplasmic virion assembly sites. However, in 
cells treated with active endocytosis inhibitors gD was 
mostly present close to the PM and very few gD-positive 
capsids were observed. We confirmed these data by 
quantification of gD-positive capsids, which revealed that 
only 30 and 39 % of VP26-mTurquoise puncta 
colocalized with gD staining after the treatment with 
Dynole and PitStop 2, respectively. In contrast, in control 
cells (Dynole Negative and Pitstop 2 negative-treated) > 
70 % of capsids were gD-positive, clearly showing that 
the treatment with active endocytosis inhibitors 
decreases gD transport to assembling virions. 
 
Localization of the TGN. Previous studies suggested 
that the TGN might provide membranes for HSV-1 
assembly [17–19]. Here we show that glycoproteins 
traffic to intracellular capsid-positive assembly sites from 
the PM. To show glycoprotein delivery to intracellular 
capsids in relation to TGN localization we infected HFF-
Tert cells with a fluorescent virus expressing VP26-
EYFP (capsid) that has been deleted for the gE gene 
(VP26-YFP/gE) for 8 h. We used a virus lacking gE to 
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avoid any non-specific reactivity of the widely used 
sheep polyclonal anti-TGN46 antibody with the gE/gI 
complex of HSV-1, which is a potent Fc-receptor [27]. 
Before fixing the cells, gH specific antibodies were 
added to media for uptake for 15 or 30 min. VP26- and 
gH-positive puncta were observed in the cytoplasm at 
both time points, demonstrating endocytic delivery of gH 
to assembling virions (Figure 5). In contrast the TGN 
was clearly distinct from these assembly sites, with the 
vast majority of TGN46 signal being localized to the 
perinuclear region, whereas internalized gH and VP26-
positive puncta were more dispersed through the 
cytoplasm. We also observed occasional puncta positive 
for both internalized gH-specific antibodies and TGN46, 
suggesting internalized viral glycoproteins can reach 
TGN46 containing compartments. The presence of 
TGN46 in vesicles containing endocytosed gH could 
arise from the endocytosis of TGN46 following it’s 
transport to the PM, or fusion of TGN46-bearing vesicles 
that originate from the TGN with endocytic 
compartments containing internalized gH, or a 
combination of both. However, we did not observe 
detectable co-localization of TGN46 to assembled 
virions in the cytoplasm (internalized gH and VP26 
positive puncta). While we cannot rule out the presence 
of small amounts of TGN46 at HSV-1 assembly sites, 
our data suggests virion envelopment occurs at 
compartments more characteristic of endosomes than 
the bulk TGN. 
 
Glycoproteins undergo endocytosis in distinct 
complexes and reach assembling virions at different 
rates. Many HSV-1 envelope proteins such as gB, gE, 
gM, as well as several others, contain potential 
endocytosis motifs (e.g. tyrosine-based motifs), which 
can enable their interactions with clathrin adaptors, 
some of which have been shown to be important for 
glycoprotein endocytosis [28,29]. In contrast gD and gH 
do not have any predicted trafficking motifs and their 
endocytosis is dependent on interactions with other viral 
glycoproteins [9,10,12]. For these reasons, we 
investigated potential glycoprotein complexes during 
endocytosis. By using the dual-fluorescent VP26-
mTurquoise/gM-EYFP virus, we were able to visualize 
capsids and the total amount of gM. Cells were infected 
for 8 h and antibodies against gB, gE, gD and gH/gL 
were added to the extracellular media to allow for uptake 
in various combinations 15 min before fixing the cells. 
Figure 6A and Figure S4B shows some of the 
combinations of tested glycoprotein antibodies. As 
predicted, gD and gH/gL did not appear able to enter 
cells alone and were found to co-localize with tyrosine 
motif-containing glycoproteins (either gB, gE or gM). In 
the case of gH/gL, substantial co-localization was 
observed with gM. In case of gD, it frequently co-
localized with gM, however some gD-gB puncta (without 
gM) were also visible. While we cannot conclude that gD 
or gH/gL are physically interacting with these other 
glycoproteins, these data suggest that either the co-
localizing glycoproteins are endocytosed together in the 
same vesicles, or if they are in separate vesicles these 
fuse rapidly after endocytosis (within the 15 min 
incubation period). Interestingly, internalized gE and gB, 
as well as gM could be detected in separate puncta 
(Figure 6A bottom panels), suggesting these tyrosine-
motif containing glycoproteins can mediate their own 
endocytosis independently of each other.  
In Figure 6A, blue circles highlight examples of viral 
particles containing all labeled components. Yellow 
arrows point to examples of incomplete labeling, 
indicating that different combinations of glycoproteins 
can be endocytosed in the same vesicles. Finally arrows 
in red, green and blue indicate examples of the presence 
of only one glycoprotein confirming that gB, gE and gM 
do not require each other for endocytosis. Observed 
capsid-free puncta might represent the endocytic 
vesicles but also light particles, which are essentially 
capsid-less virions. 
In addition, we observed that not all glycoproteins 
appear to be transported to virion assembly 
compartments at the same pace because fewer capsids 
were labeled with internalized gE antibodies compared 
to gD or gH/gL. To quantify this effect, we counted 
intracellular capsids from several cells and fields of view 
for each sample and scored them as positive or negative 
for each internalized glycoprotein in two independent 
experiments (Figure 6B). Almost all capsids contained 
gM-EYFP (93 %), demonstrating that the majority of the 
cytoplasmic capsids that are detected at this time point 
are associated with the viral envelope. gD and gH 
appear to be transported to assembly compartments 
quite rapidly; within 15 min of antibody uptake 71 and 77 
% of capsids co-localized with gD and gH, respectively. 
60 % of capsids were positive for gB but only 42 % for 
gE at this time point. In order to look at this phenomenon 
in more detail, we performed a time course where gD 
and gE specific antibodies were added to cells for 5, 15, 
30 and 60 min (Figure 6C). gD was very rapidly 
translocated to capsids and within 5 min of uptake 60 % 
of capsids were gD positive. gE transport to capsids was 
less efficient and even after 60 min of antibody uptake 
only 70 % of capsids appeared gE positive (in contrast to 
>80 % with gD). It is important to note that for the 
quantification of capsids that co-localize with internalized 
glycoproteins, intact virions attached to the extracellular 
surface of cells would also be scored in these assays. 
For all these analyses we quantified virions that were 
clearly within the boundary of the cell membrane and not 
at the edges of cells to reduce the potential impact of 
extracellular virions on our data. In addition, to 
investigate the contribution of extracellular virions to our 
quantification we performed antibody labeling of live 
cells at 4ºC prior to fixation, as well as labeling of fixed 
but non-permeablised cells with antibodies to both gD or 
gE in two independent experiments. Fluorescent capsids 
were then scored as either positive or negative for 
glycoprotein antibody. These data consistently 
demonstrated 25-30% of capsids were positive for 
glycoprotein antibody, suggesting this is the average 
proportion of capsids that are extracellular in these 
assays. Overall, these results show that glycoproteins 
can travel to assembly sites in various complexes or 
potentially alone, and importantly they are transported at 
different rates. 
 
Clathrin and caveolae both contribute to 
endocytosis of HSV-1 glycoproteins. Our experiments 
with dominant-negative dynamin and AP180 as well as 
endocytosis inhibitors showed that inhibition of dynamin 
function had a stronger effect on targeting glycoproteins 
to HSV-1 envelopment sites than inhibition of clathrin 
assembly. This suggested that clathrin-independent 
endocytosis could also contribute to HSV-1 envelope 
protein delivery to assembly sites. To address this 
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question, we used super-resolution microscopy, 
specifically direct stochastic optical reconstruction 
microscopy (dSTORM) [30]. Conventional microscopy 
techniques are limited to a resolution of ca. 250 nm due 
to optical diffraction and therefore small vesicles located 
in close proximity to one another cannot be 
distinguished. Single molecule localization methods like 
dSTORM are not limited in this way by diffraction and 
can distinguish objects as close as 20 nm apart. We 
have previously used dSTORM to analyze the structure 
of HSV-1 particles [31]. Here we used dSTORM to 
investigate the colocalization of glycoproteins with the 
endocytic machinery. We labeled infected cells with 
antibodies to HSV-1 glycoproteins together with 
antibodies to the clathrin adaptor protein AP2 or the 
caveolae marker Caveolin 1 (Cav-1). Here, we also used 
the VP26-mTurquoise/gM-EYFP virus to identify viral 
capsids and envelope. Cells were infected for 8 h and 
glycoprotein-specific antibodies were incubated with the 
cells for uptake for the last 15 min before fixation. Figure 
7 shows AP2 and Cav-1 labeling with antibody uptake 
for gD. Images clearly show the presence of gD in AP2 
positive clusters, with dSTORM analysis demonstrating 
the co-localization of gD and AP2 within the same 
structures (Figure 7A). Furthermore, localization of gD in 
Cav-1 positive clusters was also observed (Figure 7B). 
Caveolae are small invaginations of the PM found in 
many mammalian cells that are often observed 
associated with lipid rafts and thought to mediated 
clathrin-independent endocytosis of certain cargo [32]. In 
our images they appear as aggregates in contrast to 
often single, round shaped AP2-positive clusters. Similar 
results demonstrating colocalization of gE with both AP2 
and Cav-1 were also observed (Figure S5). Although 
further research is necessary to understand the 
mechanism of HSV-1 glycoprotein endocytosis, our 
study suggests a role for both clathrin-dependent and 
independent pathways in endocytic delivery of envelope 
proteins to virus assembly compartments.  
 
 
Discussion 
 
The identity of the cytoplasmic membrane 
compartment(s) where final HSV-1 envelopment occurs 
has been the topic of much recent debate. Our data 
supports the proposal by Hollinshead and colleagues 
[20], that the cytoplasmic compartments where HSV-1 
envelopment takes place are endocytic in nature. 
Previous studies suggested that membranes wrapping 
cytoplasmic capsids originate from the TGN or MVB-
related organelles [17–19]. The TGN is a major sorting 
organelle, which directs newly synthesized proteins to 
various cellular destinations including the PM. It is 
composed of interconnected vesicles and tubules and its 
function is not limited to secretion as it also regulates 
recycling and retrograde transport from the PM. In fact 
the TGN has been shown to contain both newly 
synthesized and internalized proteins [33] and this 
recycling route is regulated by both SNARE and Rab 
proteins [34,35]. The MVBs are a heterogeneous class 
of endocytic compartments that are formed due to 
inward budding of the intralumenal vesicles (ILV) from 
the limiting membrane of endosomes during their 
maturation [36]. Therefore, the observations of 
Hollinshead and colleagues showing that HSV-1 
nucleocapsids are wrapped in membranes positive for 
an endocytic tracer [20] and our data showing the 
importance of dynamin-dependent endocytosis for 
glycoprotein delivery to assembling virions are not 
necessarily contradictory to previous research 
suggesting the TGN and/or MVB as the origin of 
wrapping membranes. Cellular membrane traffic within 
the secretory and endocytic pathways comprises of a 
network of highly dynamic and interconnected 
compartments that shuffle proteins between each other 
using vesicles carriers and/or direct fusion, and so, not 
surprisingly, the content of different compartments can 
mix in various locations. In fact, during later stages of 
HSV-1 lytic infection, the membranes of the secretory 
and endocytic pathways are likely to be packed with viral 
glycoproteins, thus assessing the origin of these 
membranes is not straightforward. Therefore, while it is 
clear that the HSV-1 assembly compartment(s) receive 
endocytic cargo, and that endocytic transport routes are 
important for virus production, it is difficult to assign a 
precise definition for HSV-1 assembly sites, which are 
likely to be quite heterogeneous. 
 
Further to this, it is important to note that the 
requirement for the activity of the ESCRT machinery 
during HSV-1 envelopment does not necessarily indicate 
MVBs as budding/wrapping sites for HSV-1 [16,23,25]. 
The ESCRT machinery (which is normally responsible 
for ILV budding during MVB formation) is relatively 
mobile and can be recruited to multiple cellular 
membranes under different conditions, and so the 
involvement of the ESCRT machinery in itself does not 
allow any firm conclusions to be drawn on sites of HSV-1 
envelopment. Indeed the ESCRT machinery is involved 
in the budding of several other enveloped virus families 
at the plasma membrane and abscission at the end of 
cytokinesis, demonstrating ESCRT activity at multiple 
different subcellular locations [37,38]. 
 
Our results clearly show that dynamin-dependent 
endocytosis plays a major role in glycoprotein delivery to 
cytoplasmic virus assembly sites. Experiments with 
dominant-negative dynamin and with the dynamin 
inhibitor Dynole show significant decrease in infectious 
virus production and glycoprotein trafficking to 
cytoplasmic capsids. It should be noted that dynamin 
has been shown to be important for the entry of HSV-1 
in some cell lines, such as keratinocytes [39], which 
could complicate the interpretation of data on HSV-1 
replication in dominant-negative dynamin expressing 
cells. However, the entry of HSV-1 has recently been 
shown to be independent of dynamin in several epithelial 
cell lines [40], and we do not detect any difference in 
viral gene expression between cells expressing wild type 
or dominant-negative dynamin in our experiments with 
the epithelial cell line COS7. We therefore consider it 
unlikely that our results are due to effects of dominant-
negative dynamin on virus entry. 
 
Interestingly we observed that some infectious viruses 
are still produced under conditions of dynamin inhibition. 
This could be explained by incomplete inhibition of 
dynamin activity in our experimental setting. 
Alternatively, dynamin-independent endocytosis 
pathways might also contribute to glycoprotein delivery, 
or glycoproteins could be trafficked directly to assembly 
sites without trafficking via the PM. Interestingly Rab6-
dependent exocytosis of glycoproteins has been shown 
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to be crucial for the secondary envelopment of HSV-1 
[15], suggesting viral envelope proteins must exit the 
Golgi/TGN to gain access to assembly sites. In 
agreement with this, our experiments demonstrate that 
the majority of assembled viruses are wrapped in 
membranes that are at least partially derived from the 
PM via dynamin-dependent endocytosis. However, we 
cannot exclude that in some conditions, especially when 
other pathways are blocked, glycoproteins can traffic 
directly to the assembly sites bypassing the PM. It is 
also possible that during the inhibition of dynamin 
activity, virus glycoproteins are able to engage dynamin-
independent endocytosis routes, which results in limited 
production of infectious virions.  
 
Many HSV-1 glycoproteins, including gE, gB and gM 
contain motifs allowing them to interact with clathrin 
adaptors [28,29], and thus should be able to enter cells 
via endocytosis independently of other viral proteins. In 
our experiments these glycoproteins appear as single 
puncta in antibody uptake experiments. In contrast we 
have previously shown that gD and gH/gL do not encode 
their own internalization motifs and require other 
endocytosis motif-containing viral glycoproteins, such as 
gM, for their internalization [9,10,12]. Our data here also 
support this notion as we only observe internalized gD or 
gH/gL when they are co-localized with other viral 
glycoproteins (namely gM or gB for gD and only gM for 
gH/gL).  
 
Our observation that inhibition of clathrin assembly has a 
less pronounced effect on infectious virus production or 
glycoprotein internalization than the inhibition of dynamin 
suggests that clathrin-independent endocytosis also 
contributes to glycoprotein delivery from the plasma 
membrane to assembly sites. Interestingly, we observed 
that both gD and gE colocalize not only with AP2 but 
also with caveolae marker Cav-1. The role of caveolae in 
HSV-1 assembly is not within the scope of this present 
study. However, it will be interesting to assess in the 
future whether caveolae or other clathrin-independent 
endocytosis pathways contribute significantly to 
glycoprotein delivery. Furthermore, investigating the 
mechanisms involved in these processes during HSV-1 
replication may provide important information on these 
cellular pathways, as the role of caveolae in endocytosis 
is still much debated [41,42]. 
 
Our study clearly confirms the importance of dynamin-
dependent endocytosis for targeting HSV-1 envelope 
proteins to sites of virion assembly. However, it is 
intriguing to speculate why HSV-1 glycoproteins have to 
travel via the PM for their efficient targeting to assembly 
sites and why they do not use more direct routes from 
the secretory pathway (i.e. the Golgi/TGN) to sites of 
secondary envelopment that would avoid exposure of 
viral glycoproteins to the extracellular environment. One 
tempting hypothesis is that transporting viral 
glycoproteins via the plasma membrane into endocytic 
organelles is necessary to gather the large number of 
different viral membrane proteins that are incorporated 
into mature virions in the same membrane compartment. 
Given that the different viral envelope proteins (up to 16 
for HSV-1) have varying expression kinetics, using a 
subcellular compartment that receives large quantities of 
endocytosed cargo, such as the recycling endosome, 
could serve as an efficient mechanism to bring all these 
membrane proteins together for secondary envelopment. 
As such, the PM could be considered a principal sorting 
organelle for HSV-1 proteins, with the process of 
packaging viral envelope proteins into endocytic vesicles 
having the effect of concentrating them within the 
receiving endocytic compartment. Furthermore, 
interactions between various glycoproteins as well as 
underlying tegument proteins could be acquired during 
this transport to and from the PM.  
 
In summary, our data demonstrate that dynamin-
dependent endocytosis is a major pathway for 
transporting HSV-1 envelope proteins to intracellular 
sites of virus assembly. In the future it will be important 
to investigate the transport of the other viral membrane 
proteins as well as membrane associated tegument 
proteins, and how all the structural components come 
together to form mature viruses. A key question yet to be 
answered is whether HSV-1 envelope proteins are 
transported as discrete subcomplexes, perhaps with 
associated tegument proteins, as this will shed further 
insights into the assembly of these large and complex 
viruses. 
 
 
Experimental Procedures 
 
Cell lines and viruses. Vero cells (ATCC), COS7 cells 
(ATCC) and telomerase immortalized human foreskin 
fibroblasts (HFF-Tert) were grown in DMEM 
supplemented with 10 % fetal bovine serum, 2 mM 
glutamine, 100 U.ml-1 penicillin and 100 g.ml-1 
streptomycin. HaCaT cells [43] were maintained in 
Glasgow minimal essential medium supplemented with 
10 % fetal bovine serum, 2 mM glutamine, 100 U.ml-1 
penicillin and 100 g.ml-1 streptomycin. The UL36 
complementing cell line (HS30; grown with addition of 
200 mg.ml-1 of G418) and HSV-1UL36 virus were a gift 
from P. Desai, John Hopkins University [44]. Strain KOS 
of HSV-1 genome cloned as a bacterial artificial 
chromosome was used in this study [45]. Recombinant 
VP26-mTurquoise/gM-EYFP virus was described 
previously [31]. Recombinant VP26-YFP/gE virus was 
generated by co-infecting cells with HSV-1gE-lacZ 
(described in [46]) and HSV-1-VP26-YFP (described in 
[47]), followed by selection of plaque purified 
recombinant virus both expressing VP26-YFP and 
lacking gE expression. 
 
Antibodies and reagents. Monoclonal antibodies 
against viral proteins were all described previously: gD 
(LP2, AP7, AP12, LP14) [48], gH (LP11 [49], BBH-1; 
Abcam, ab110227), gB (CB24) [50], gE (3063, 3114) 
[51], VP16 (LP1; Abcam, ab110226) [52], UL36 (CB4) 
[53]. VP5 (ab6508), anti-alpha Adaptin antibody (AP2) 
[AC1-M11], anti-Actin antibody [AC-40], anti-HA tag 
antibody [16B12] and Protein A conjugate to HRP 
(ab7456) were from Abcam. Anti-Caveolin-1 (610406) 
and anti-GM130 (610822) were from BD Bioscience. 
Anti-Myc tag (9E10) was from Sigma-Aldrich. Anti-GFP 
antibody JL8 was from Clontech. TGN-46 antibody was 
from Dr. S. Ponnambalam (University of Leeds). LI-COR 
antibodies for WB detection were from LI-COR 
Biosciences. All secondary Alexa Fluor antibodies and 
Transferrin AF-568 were from Molecular Probes. 
Dynamin inhibitors: Dynole™ Series Kit (ab120474) 
including Dynole-34-2 (Dynole) and Dynole-31-2 (Dynole 
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Negative) were used at 15 M, while Pitstop 2™ 
(ab120687) and Pitstop2 negative control (ab120688) at 
30 M. Dilutions were prepared in serum-free medium. 
All inhibitors were purchased from Abcam. 
 
Dominant-negative protein assays. Wild type HA-
dynamin 2 pcDNA3.1 (34684) and K44A HA-dynamin 2 
pcDNA3.1 (34685) were obtained from Addgene. 
AP180-C myc and VPS4 EQ YFP were described 
previously [24,54]. Plasmids of interest or empty 
pcDNA3.1 were co-transfected with pcDNA-UL36 [25] or 
empty control plasmid into COS7 cells. Next day cells 
were infected at multiplicity of infection (MOI) of 5 
PFU.ml-1 with HSV-1UL36 virus. After 16 h infection 
cells and supernatants were harvested together and 
prepared for titration by three freeze-thaw cycles. Virus 
titers were assessed using the UL36 complementing cell 
line HS30. Cells for WB analysis were lysed with 1 % 
Triton X-100 in PBS with protease inhibitors cocktail 
(Roche) and run on SDS-PAGE followed by detection of 
VP16 and Actin. Cells for immunostaining were fixed 
with 4 % ultra-pure formaldehyde (Polysciences, cat # 
04018-1) 10 h after infection. Antibodies specific to gD 
(LP2) were added 15 min before fixing. For transferrin 
uptake cells were transfected with pcDNA3.1, dominant 
negative AP180, Dynamin WT or Dynamin K44A for 24 
h. Cells were incubated with Transferrin Alexa-Fluor-568 
for 5 min in serum-free medium. After fixing and 
permeabilisation immunodetection of HA-tag and Myc-
tag was performed. 
 
Neutralization assay. HaCaT and COS7 cells were 
seeded on 24-well plates at 105 cells per well 1 day prior 
to infection with HSV-1 at MOI = 3. After 1 h cells were 
incubated with acid wash (40 mM citric acid, 135 mM 
NaCl, 10 mM KCl, pH 3.0) for 1 min to inactivate residual 
virus particles that had not entered cells. After 3 washes 
with PBS, fresh medium containing 5 g/ml of purified 
monoclonal antibodies directed to VP16, gD and gH was 
added to the cells. VP16 tegument protein antibody was 
used as negative control. For each glycoprotein 
neutralizing (LP2 and LP11) and non-neutralizing (AP7 
and BBH-1) antibody was used. Cells were incubated 
with antibodies for 16 h then washed with PBS and 
trypsinized for 10 min to remove all extracellular 
infectivity. After pelleting cells and washing with PBS, 
cells were resuspended in complete media, subjected to 
freeze-thaw three times and intracellular viruses were 
titrated using Vero cells. Wells used for WB analysis 
were washed with PBS and lysed with 1 % Triton X-100 
in PBS with protease inhibitors cocktail (Roche). 
Supernatants for WB analysis of secreted particles were 
collected and cellular debris was removed by two 
subsequent centrifugations at 6200 x g for 10 min. 
Viruses were pelleted by ultracentrifugation at 75,000 x g 
for 3 h at 4˚C using a Beckman Coulter TLA-55 rotor. 
Pellets were lysed and run on SDS-PAGE. All proteins 
were detected with specific primary antibodies and 
secondary LI-COR antibodies. gD was detected using 
Protein-A HRP and ECL to avoid detection of antibodies 
used in uptake assay, which migrate on SDS-PAGE gels 
at a similar position as gD.  
 
Immunofluorescence assay. All samples were fixed for 
10 min using 4 % ultra-pure formaldehyde. 
Permeabilisation was performed with 0.1 % Triton X-100 
in PBS for 5 min. Cells were then blocked with 2 % FBS 
for 30 min and incubated with primary antibodies for 1 h. 
For some experiments primary antibodies specific to 
viral glycoproteins were added for uptake before cells 
were fixed. Isotype specific secondary antibodies 
conjugated to AlexaFluor dyes were used for detection. 
Cells were imaged using epifluorescence microscope 
(Olympus IX81) or confocal microscope (Zeiss LSM780).  
 
Wide-field fluorescence, bright field and dSTORM 
imaging. Imaging was performed on an inverted TIRF 
microscope (Nikon TE-300) custom-built for dSTORM 
acquisition, as previously described [31,55,56], using 
highly inclined illumination [57]. The microscope was 
equipped with an iXon3 897 EM-CCD camera (Andor, 
UK). The following laser and filter combinations were 
used: 640 nm diode laser (either iBeam Smart, Toptica, 
Germany) and filter 676/37 (Semrock, USA) for AF647, 
561 nm laser (DPSS laser, Oxxius, France) and 607/70 
(Semrock, USA) for AF568, 491 nm (DPSS laser, 
Cobolt, Sweden) and 530/55 (Semrock, USA) for EYFP 
and 405 nm diode laser with 530/55 (Semrock, USA) for 
mTurquoise. The wide-field fluorescence images were 
taken before the dSTORM acquisition using low power 
illumination (~1mW), acquiring a 50-frames stack (100 
ms exposure). The bright field images were taken after 
the dSTORM imaging to minimize photobleaching from 
the transmitted light illumination, acquiring a 50-frames 
stack (100 ms exposure). For the two-color dSTORM 
acquisition, 16,000 – 20,000 frames were sequentially 
acquired for AF647 and AF568 at a frame rate of ~65 Hz 
(15 ms exposure) with irradiation intensities at 1-5 
kW/cm² in switching buffer (100 mM mercaptoethylamine 
(MEA, Sigma) in phosphate buffered saline solution 
(PBS), pH 7.2). 
 
Image analysis. The wide-field fluorescence and bright 
field images were obtained by averaging the 50-frames 
stack. Additionally, the continuous background was 
removed from the wide-field fluorescence images by 
applying a rolling-ball algorithm [58]. All dSTORM 
dataset were analyzed using rapidSTORM 3.3 [59]. For 
the two-color dSTORM, the chromatic offset between the 
two channels was corrected by using localization-based 
correction using a custom-written MATLAB (The 
MathWorks) routine [60]. The chromatic transformations 
were obtained from the combination of multiple fields of 
view containing randomly distributed white fluorescent 
microspheres (100 nm TetraSpeck microsphere, 
Invitrogen). 
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Figure Legends 
Figure 1. Glycoprotein specific neutralizing 
antibodies incorporated into virions during 
assembly affect intracellular HSV-1 infectivity. A. 
HaCaT cells were infected with HSV-1 at MOI = 3 and 
then incubated with 5 g.ml-1 of antibodies (LP1 for 
VP16, LP2 and AP7 for gD and LP11 and BBH-1 for gH) 
for 16 h. To remove and inactivate extracellular viruses 
cells were trypsinized for 10 min. Cells pellets were 
washed, resuspended in media and intracellular virus 
released by three freeze-thaw cycles and then titrated 
using Vero cells.  Data are represented as mean ± SD 
from at least three independent experiments with each 
experiment containing 2 biological replicates per 
condition. T-tests were performed with Graphpad Prism. 
**** P value < 0.0001, *** P < 0.0005, ** P < 0.005. 
Additional cell pellet samples were lysed in PBS + 1% 
Triton X100 + protease inhibitors and analyzed by WB 
for the presence of VP16, actin and gD. B. HaCaT cells 
were infected and incubated with antibodies as before. 
Supernatants were collected and cleared of cellular 
debris by centrifugation. Secreted viruses were pelleted 
by ultracentrifugation for 3 h at 75,000 x g and analyzed 
by WB. In the WB analyses, the secondary anti-mouse 
antibodies used for detection of VP16 and Actin (A) or 
VP16 and gE (B) also detected the denatured IgG heavy 
chains (IgGH) of the antibodies internalized into cells. To 
avoid detection of internalized antibody heavy chains on 
gD blots (as both migrate at similar size) Protein A 
conjugated to HRP and ECL detection was used. 
 
Figure 2. Dominant-negative dynamin and AP180 
impairs the production of infectious HSV-1. A. COS7 
cells were co-transfected with plasmid expressing UL36 
protein and plasmids containing dominant-negative 
(K44A) or wild type (wt) Dynamin, dominant-negative 
AP180-C and VSP4-EQ or empty pcDNA vector control. 
Cells were then infected with HSV-1UL36 and after 16 
h processed for titration in HS30 cells or for WB analysis 
of cell lysates. Data are represented as mean ± SD from 
at least three independent experiments with each 
experiment containing 2 biological replicates per 
condition. T-tests were performed with Graphpad Prism. 
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**** P value < 0.0001, *** P < 0.0005 B. Transferrin 
uptake into COS7 cells transfected with pcDNA and WT 
dynamin controls and dominant/negative dynamin and 
AP180 was followed by immune-detection of transfected 
cells by anti-Myc or anti-HA antibodies. Asterisks are 
highlighting transfected cells. Scale bar = 20 m. C. WT 
or K44A dynamin-transfected COS7 cells were infected 
with VP26-mTurquoise/gM-EYFP for 8 h and then fed 
with anti-gD antibody (LP2) for 15 min before fixing. 
Cells were then permeabilised and immunostained with 
anti-HA followed by secondary antibody labeling. Images 
were acquired using a confocal microscope. Blue circles 
in the zoom-in section represent virus particles 
containing both gD and VP26. Scale bar = 10 m 
 
Figure 3. Effect of endocytosis inhibitors on uptake 
of transferrin and glycoproteins into HFF-Tert cells. 
A. Cells were incubated with DMSO, 15 M Dynole or 
Dynole negative control and 30 M PitStop2 or its 
negative control for 15 min. Next transferrin conjugated 
to AlexaFluor 568 was added for 5 min. Cells were then 
washed on ice, fixed and imaged using an 
epifluorescence microscope. Scale bar = 20 m B. Cells 
were infected with HSV-1 for 8 h. For the last 30 min 
cells were incubated with DMSO, 15 M Dynole or 
Dynole negative control and 30 M PitStop2 or its 
negative control. After 15 min incubation antibodies 
specific to viral glycoproteins (LP2 for gD, 3063 for gE, 
CB24 for gB, LP11 for gH) were added and incubated for 
a further 15 min. After fixation, cells were permeabilized 
and stained with secondary antibodies and imaged by 
epifluorescence microscopy. Scale bar = 20 m 
 
Figure 4. Endocytosis inhibitors impair transport of 
glycoproteins to cytoplasmic capsids. HFF-Tert cells 
were infected with VP26-mTurquoise/gM-EYFP 
recombinant virus for 8 h. 30 min before the end of 
incubation cells were treated with 15 M Dynole or 
Dynole negative control and 30 M PitStop2 or its 
negative control. After 15 min antibodies specific to gD 
(LP2) were added and incubated for a further 15 min. 
Cells were then fixed, permeabilised and labeled with 
secondary antibodies. Images were acquired using a 
confocal microscope. Blue circles are highlighting 
complete viral particles while yellow arrows point to 
particles missing gD staining. Scale bar = 2 m. Right 
panels show percentage of intracellular capsids (VP26-
mTurquoise) co-localizing with gD. At least 100 capsids 
from multiple cells and several fields of view were 
counted for each condition. Graphs represent the 
percentage of capsids positive for gD labeling as mean 
from two independent experiments ± SEM. 
 
Figure 5. Localization of assembly sites in relation to 
TGN compartment. HFF-Tert cells were infected with 
VP26-YFP/gE virus for 8 h. gH specific antibodies were 
added to cells for uptake for 15 or 30 min before fixation 
and permeabilisation. Sheep anti TGN-46 antibodies 
were used to image TGN, followed by secondary Alexa 
Fluor antibodies. Scale = 10 m.  
 
 
Figure 6. Glycoproteins undergo endocytosis in 
various complexes. A. HFF-Tert cells were infected 
with VP26-mTurquoise/gM-EYFP recombinant virus for 8 
h. Antibodies specific to HSV-1 gD, gB, gH and gE were 
added in various combinations for the last 15 min of 
incubation. After fixing and permeablilisation isotype-
specific secondary Alexa-Fluor antibodies were used 
and images were acquired using a confocal microscope. 
Blue circles are showing particles containing all labeled 
components. Yellow arrows point to dots containing only 
some components, while red, green and blue arrows 
point to dots containing only one type of glycoprotein. 
Scale bar = 2 m.  B. Quantification of images obtained 
as for Figure 5A. At least 100 capsids from multiple cells 
and several fields of view were counted for each 
combination of glycoproteins. Graph represents the 
percentage of capsids positive for each glycoprotein 
labeling as mean from six combinations of antibodies 
obtained in two independent experiments ± SEM. gM 
was imaged as fusion to EYFP while other glycoproteins 
were imaged after primary antibody uptake into cells for 
15 min before fixation.  C. Kinetics of gD and gE 
transport to intracellular capsids. Cells infected with 
VP26-mTurquoise/gM-EYFP virus were incubated for 8 
h and then fixed with 4 % formaldehyde. At 60, 30, 15 
and 5 min before fixing gD (LP2) and gE (3063) 
antibodies were added to cells for uptake. At least 100 
capsids from multiple cells and several fields of view 
were counted for each condition. Data are represented 
as mean from two independent experiments ± SEM. 
 
Figure 7. dSTORM images of clathrin and caveolae-
dependent endocytosis of gD. HFF-Tert cells were 
infected with VP26-mTurquoise/gM-EYFP recombinant 
virus for 8 h. gD specific antibodies were added to cells 
for uptake 15 min before fixation and permeabilisation. 
Clathrin-coated pits or caveolae were detected with anti 
AP-2 (A) or Cav-1 (B) monoclonal antibodies and 
subtype-specific secondary Alexa Fluor antibodies. Wide 
field images were acquired for all channels. dSTORM 
images of gD (Alexa Fluor 568 channel) and AP2/Cav1 
(Alexa Fluor 647 channel) are shown. Scale = 10 m, 
500 nm and 200 nm. 
 
Figure S1. Antibodies incorporated into virions 
during assembly affect HSV-1 infectivity. A. COS7 
cells were infected with HSV-1 at MOI = 3 and then 
incubated with 5 g.ml-1 of antibodies (LP1 for VP16, 
LP2 and AP7 for gD and LP11 and BBH-1 for gH) for 16 
h. To remove and inactivate extracellular viruses cells 
were trypsinized for 10 min. Pellets were washed and 
harvested for titration in Vero cells by three freeze-thaw 
cycles. Additional cell pellet samples were lysed in PBS 
+ 1 % Triton X100 + protease inhibitors and analyzed by 
WB for the presence of VP16 and actin. Secondary anti-
mouse antibodies used for detection were also able to 
detect the heavy chains of antibodies used for uptake 
(IgGH). Data are represented as mean ± SD from at least 
three independent experiments with each experiment 
containing 2 biological replicates per condition. B. COS7 
cells were infected with VP26-mTurquoise/gM-EYFP 
virus and incubated with 5 g.ml-1 of gD specific 
antibodies (LP2) for 16h. Cells were then fixed, 
permeabilised and labeled with primary antibodies to 
GM130 followed by isotope-specific secondary Alexa-
Fluor antibodies. Cells were imaged by confocal 
microscope. Scale bar = 10 m. 
 
Figure S2. Dominant-negative dynamin decreases 
endocytosis of gB and gE. WT or K44A dynamin-
transfected COS7 cells were infected with VP26-
mTurquoise/gM-EYFP for 8 h and then fed with anti-gB 
Page 12 of 25Traffic
For Peer Review
 
(CB24) or gE (3114) antibodies for 15 min before fixing. 
Cells were then permeabilised and immunostained with 
antibodies anti-HA followed by secondary antibodies 
labeling. Images were obtained using epifluorescence 
microscope. Scale bar = 10 m. 
 
 
Figure S3. Effect of endocytosis inhibitors on uptake 
of transferrin and glycoproteins into COS7 cells. A. 
Cells were incubated with DMSO, 15 M Dynole or 
Dynole negative control and 30 M PitStop2 or its 
negative control for 15 min. Next transferrin conjugated 
to AlexaFluor 568 was added for 5 min. Cells were then 
washed on ice, fixed and imaged using an 
epifluorescence microscope. Scale bar = 20 m B. Cells 
were infected with HSV-1 for 8 h. For the last 30 min 
cells were incubated with DMSO, 15 M Dynole or 
Dynole negative control and 30 M PitStop2 or its 
negative control. After 15 min incubation antibodies 
specific to viral glycoproteins (LP2 for gD, 3063 for gE, 
CB24 for gB, LP11 for gH) were added and incubated for 
a further 15 min. After fixing and permeabilizing, cells 
were stained with secondary antibodies and imaged by 
epifluorescence microscopy. Scale bar = 20 m. 
 
Figure S4. Low power images corresponding to 
Figures 4 and 6. A. HFF-Tert cells were infected with 
VP26-mTurquoise/gM-EYFP recombinant virus for 8 h. 
30 min before the end of incubation cells were treated 
with 15 M Dynole or Dynole negative control and 30 M 
PitStop2 or its negative control. After 15 min antibodies 
specific to gD (LP2) were added and incubated for a 
further 15 min. Cells were then fixed, permeabilised and 
labeled with secondary antibodies. Images were 
acquired using a confocal microscope. Scale bar = 10 
m. B. HFF-Tert cells were infected with VP26-
mTurquoise/gM-EYFP recombinant virus for 8 h. 
Antibodies specific to HSV-1 gD, gB, gH and gE were 
added in various combinations for the last 15 min of 
incubation. After fixing and permeablilisation isotype-
specific secondary Alexa-Fluor antibodies were used 
and images were acquired using a confocal microscope. 
Scale bar = 5 m. 
 
Figure S5. dSTORM images of clathrin and caveolae-
dependent endocytosis of gE. HFF-Tert cells were 
infected with VP26-mTurquoise/gM-EYFP recombinant 
virus for 8 h. gE specific antibodies were added to cells 
for uptake 15 min before fixation and permeabilisation. 
Clathrin-coated pits or caveolae were detected with anti 
AP-2 (A) or Cav-1 (B) monoclonal antibodies and 
subtype-specific secondary Alexa Fluor antibodies. Wide 
field images were acquired for VP26 (blue), gM (yellow) 
and merged with dSTORM images of gE (Alexa Fluor 
568 channel) and AP2/Cav1 (Alexa Fluor 647 channel). 
Scale = 10 m, 500 nm and 200 nm. 
 
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